Followers | 14 |
Posts | 1,650 |
Boards Moderated | 0 |
Alias Born | 11/01/2010 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
we've been in this range for a couple months now
$INNV With these updates coming out, anyone who is short should cover. More eyes are looking at this company now.
$INNV INNOVUS PHARMA (OTCMKTS:INNV) Short Interest Increased By 838.44%
http://www.consumereagle.com/innovus-pharma-otcmktsinnv-short-interest-increased-by-838-44/141240/
The stock of INNOVUS PHARMA (OTCMKTS:INNV) registered an increase of 838.44% in short interest. INNV’s total short interest was 600,600 shares in August as published by FINRA. Its up 838.44% from 64,000 shares, reported previously. With 4.64M shares average volume, it will take short sellers 0 days to cover their INNV’s short positions. The stock decreased 5.12% or $0.02 on August 17, hitting $0.371. About 1.07 million shares traded hands. Innovus Pharmaceuticals Inc (OTCMKTS:INNV) has risen 430.00% since January 13, 2016 and is uptrending. It has outperformed by 417.65% the S&P500.
Innovus Pharmaceuticals, Inc. is a pharmaceutical firm engaged in the commercialization, licensing, and development of non-prescription medicine and consumer care products to improve men’s and women’s health and vitality and respiratory diseases. The company has a market cap of $26.15 million. The Firm markets approximately five products in the United States and six in a range of countries around the world through its commercial partners. It currently has negative earnings. It has commercial agreements in over 60 countries around the world through its commercial partners.
People seem interested. I check this last one but I don't see INNV paying for this in the disclosure. http://microcapspeculators.com/disclaimer/
$INNV Investors are Bullish on these Biotechs
http://www.baystreet.ca/viewarticle.aspx?id=443931
LAS VEGAS, NV / ACCESSWIRE / August 17, 2016 / Following the sharp decline of the biotech sector following the Brexit vote, the NASDAQ Biotechnology Index (NBI) has seen a very strong resurgence. The index is down about 21% and 26% from its respective 1-year high and its all time high last summer.
Since last summer's peak and subsequent low, investors have gotten a better picture of where the growth may lie. Here's a few biotechs that investors should consider:
Innovus Pharmaceuticals, Inc. (INNV), is an emerging leader in OTC and consumer products for men's and women's health and vitality. INNV has an upcoming FDA decision regarding the approval of the Fluticasone Propionate ANDA for FlutiCareâ„¢, which it has rights to market as an over-the-counter product worldwide. As a leading prescription brand with 40 million units sold in 2014, FlutiCareâ„¢ is capable of generating in excess of $100 million per year in revenue once full market penetration is achieved. FlutiCareâ„¢ would be competing with GlaxoSmithKline plc's (NYSE: GSK) Flonase®, which generated nearly $100 million in its first 16 weeks on the shelf, according to IRI figures. INNV recently announced record revenue of $1 million during the second quarter, driven by its recent acquisition of Beyond Human and organic growth across its core product lines. For the full year, management expects to reach the 'higher end' of its $3-5 million in projected revenue without factoring in any potential gains from FlutiCareâ„¢ -- a nasal allergy spray that's currently under review by the FDA. As a result, SeeThruEquity issued an update on August 15, 2016 on INNV and raised its target price to $1.00 per share.
Legal Disclaimer
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. ACR Communication, LLC. which owns Microcapspeculators.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. ACR Communication, LLC. which owns, Microcapspeculators.com may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. ACR Communication LLC. which owns Microcapspeculators.com may be compensated for its services in the form of cash-based compensation or in equity in the companies it writes about, or a combination of the two. For Full Legal Disclaimer Click Here.
SOURCE: ACR Communication, LLC
That's not anything to think about it. The first place you look to for drug info is wikipedia? Why would a OTC penny stock like Innovus ever be on Wikipedia?
Wikipedia? Are you serious? Who cares?
They are still making money from their other products
They are still making money from their other products.
I hear easily correctable could be something like changing the label on a drug
Right but we know how penny traders can be. Good thing we have other products generating revenue
That was another prediction
I think people were expecting approval within the first two weeks of August. I remember reading that on here a couple weeks ago.
It was posted. You can't read?
http://finance.yahoo.com/news/seethruequity-issues-innovus-pharmaceuticals-inc-100000012.html
Sounds good
$INNV Sounds like they are doing a pretty good job of selling the stuff already. Aren't they having trouble keeping it in stock?
he's having little to no effect IMO
The one trade today was me. I typically don't buy on the Ask but the gave me .1985 anyway
$CTDT so this info is up to Dec 2015? So there should be more to come
I don't think Google makes their recipe public but it's possible that is what people are clicking the most when searching for it
same here
Looks like it's holding. You've been calling for the price to drop for awhile but it doesn't happen.
$INNV I currently see people willing to pay at least .47 ??
$INNV lol a quick shake and now back up to .46 what a shame
$INNV still holding
I don't know if you will get shares much cheaper than this
I'm wondering if anyone seen the news. I can't see it on ihub or etrade
$INNV Ask is now.49
yeah I see the same now
it's still early but I like seeing the Ask at .56 right now
If it is real its possible it was released early by mistake. I wouldn't expect a response.
How is this insider trading when it was posted by the company?
of course if you actually have them
$INNV nice close ahead of tomorrow
nice, I wish I would've moved on Friday
Seems like two weeks is too long in pennyland
He shorted the stock
$INNV I think we will move past .60 again this week